Citation: Lm. Aledort et Dm. Dimichele, INHIBITORS OCCUR MORE FREQUENTLY IN AFRICAN-AMERICAN AND LATINO HEMOPHILIACS, Haemophilia, 4(1), 1998, pp. 68-68
Citation: Dm. Dimichele et Lm. Aledort, INHIBITOR DEVELOPMENT WITH POST-LICENSURE USE OF RECOMBINANT FACTOR-VIII (RFVIII) - THE US HEMOPHILIA REGION-II EXPERIENCE, Thrombosis and haemostasis, 1997, pp. 350-350
Citation: Gy. Chang et al., HEPARIN AND THE RISK OF INTRAVENTRICULAR HEMORRHAGE IN PREMATURE-INFANTS, The Journal of pediatrics, 131(3), 1997, pp. 362-366
Citation: I. Fligman et al., IN-VITRO FACTOR-IX (FIX) RECOVERY DURING THE DELIVERY OF HIGH-PURITY FIX CONCENTRATE (CONC) BY CONTINUOUS-INFUSION (CI), Blood, 90(10), 1997, pp. 3299-3299
Citation: Ch. Miller et al., MONITORING FOR VON-WILLEBRAND-FACTOR INHIBITORS IN PATIENTS WITH VON-WILLEBRAND-DISEASE TYPE-3, Blood, 90(10), 1997, pp. 135-135
Citation: Dm. Dimichele et Bl. Kroner, ANALYSIS OF THE NORTH-AMERICAN IMMUNE TOLERANCE REGISTRY (NAITR) (1993-1997) - CURRENT PRACTICE IMPLICATIONS, Blood, 90(10), 1997, pp. 685-685
Citation: Pm. Obrien et al., MANAGEMENT OF AN ACUTE HEMORRHAGIC OVARIAN-CYST IN A FEMALE-PATIENT WITH HEMOPHILIA-A, Journal of pediatric hematology/oncology, 18(2), 1996, pp. 233-236
Citation: Dm. Dimichele et al., IN-VITRO FACTOR-VIII RECOVERY DURING THE DELIVERY OF ULTRA-PURE FACTOR-VIII CONCENTRATE BY CONTINUOUS-INFUSION, American journal of hematology, 51(2), 1996, pp. 99-103
Citation: Gy. Chang et al., RANDOMIZED DOUBLE-BLIND CONTROL STUDY TO INVESTIGATE THE USE OF HEPARIN AND THE RISK OF INTRACRANIAL HEMORRHAGE, Pediatric research, 37(4), 1995, pp. 199-199
Authors:
SCHMIDT ML
GAMERMAN S
SMITH HE
SCOTT JP
DIMICHELE DM
Citation: Ml. Schmidt et al., RECOMBINANT ACTIVATED FACTOR-VII (RFVIIA) THERAPY FOR INTRACRANIAL HEMORRHAGE IN HEMOPHILIA-A PATIENTS WITH INHIBITORS, American journal of hematology, 47(1), 1994, pp. 36-40